By Jesús Avila
Content material: Preface; Animal versions on Alzheimer ailment; Animal versions for Amyloid/PS-1 Pathology; Transgenic mice overexpressing GSK-3beta as animal types of Alzheimer affliction; Reelin and Alzheimer disorder; Tauopathy types; Animal versions for Parkinson disorder I; Animal versions for Parkinson affliction II; Neuroprotection in Parkinson illness; Animal versions for ALS; Mouse types of Huntington's illness; Recesive Ataxias; Mouse versions in PrP-related ailments; Mouse types of ischemia
Read Online or Download Animal Models for Neurodegenerative Disease PDF
Similar biochemistry books
Aim discovery is a box that has existed for a number of years yet is so brilliant this present day as a result fresh growth in our figuring out of the molecular mechanisms of many human illnesses and the technical advances in aim id and validation. extra subtle gene profiling applied sciences, comparable to DNA microarrays and serial research of gene expression, enable quick identity of lead ambitions.
- Raman spectroscopy in biology: principles and applications
- BOOK REVIEWS The Rhizosphere: Biochemistry and Organic Substances at the Soil-Plant Interface. 2nd Edition. Edited by R. Pinton, Z. Varanini and P. Nannipieri. Boca Raton, FL, USA: CRC Press (2007), pp. 447, £86.00. ISBN 0-8493-3855-7
- Function of Quinones in Energy Conserving Systems
- Basic principles of analytical ultracentrifugation
Extra resources for Animal Models for Neurodegenerative Disease
Sample text
Khoury, G. Stephanopoulos, U. De Girolami, R. R. Ratan, R. J. Ferrante and F. Dangond, J. , 2005, 164, 10–21. 83. H. Ryu, K. Smith, S. I. Camelo, I. Carreras, J. Lee, A. H. Iglesias, F. Dangond, K. A. Cormier, M. E. Cudkowicz, R. H. Brown and R. J. Ferrante, J. , 2005, 93, 1087–1098. 84. K. N. Green, J. S. Steffan, H. Martinez-Coria, X. Sun, S. S. Schreiber, L. M. Thompson and F. M. LaFerla, J. , 2008, 28, 11500–11510. 85. A. Ricobaraza, M. Cuadrado-Tejedor, A. Pe´rez-Mediavilla, D. Frechilla, J.
Nitsch, Ann. N. Y. Acad. , 2000, 920, 285–291. 92. C. Hock, A. Maddalena, A. Raschig, F. Mu¨ller-Spahn, G. Eschweiler, K. Hager, I. Heuser, H. Hampel, T. Mu¨ller-Thomsen, W. Oertel, M. Wienrich, A. Signorell, C. Gonzalez-Agosti and R. M. Nitsch, Amyloid, 2003, 10, 1–6. 93. H. Seo, A. W. Ferree and O. Isacson, Eur. J. , 2002, 15, 498–506. 94. R. M. Nitsch, M. Deng, M. Tennis, D. Schoenfeld and J. H. Growdon, Ann. , 2000, 48, 913–918. 95. D. Mu¨ller, H. Wiegmann, U. Langer, S. Moltzen-Lenz and R.
Colton, J. , 2009, 29(25), 7957–7965. 97. K. Furukawa, B. L. Sopher, R. E. Rydel, J. G. Begley, D. G. Pham, G. M. Martin, M. Fox and M. P. Mattson, J. , 1996, 67(5), 1882–1896. 98. D. C. Lu, S. Rabizadeh, S. Chandra, R. F. Shayya, L. M. Ellerby, X. Ye, G. S. Salvesen, E. H. Koo and D. E. Bredesen, Nat. , 2000, 6(4), 397–404. 99. F. M. LaFerla, Nat. Rev. , 2002, 3(11), 862–872. 100. J. C. Dodart, C. Mathis and A. Ungerer, Rev. , 2000, 11(2–3), 75–93. 101. P. R. Turner, K. O’Connor, W. P. Tate and W.